12 Stocks Under $5 With Biggest Upside Potential

9. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Upside Potential: 90.15%

Stock Price as of January 17: $4.77

Number of Hedge Fund Investors: 31

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is a leading biotechnology company that provides a wide range of products and services, including mRNA synthesis, gene editing tools, and safety testing solutions for biopharmaceuticals. The company is dedicated to the development of next-generation medicines, with a particular focus on nucleic acid production (NAP) and biologics safety testing (BST).

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is focusing on driving innovation and developing new products to meet the evolving needs of its customers. The company introduced 21 new products year to date and is expanding its offerings in mRNA synthesis and gene editing tools. Notably, the launch of the CleanScribe RNA Polymerase, a novel enzyme that significantly reduces double-stranded RNA formation during in vitro transcription, has been well-received by top pharmaceutical companies. This product not only enhances the safety and efficacy of mRNA therapeutics but also streamlines the production process, making it a valuable addition to the company’s portfolio. Additionally, the company is expanding its TriLink’s co-transcriptional capping technology with the issuance of new patents.

Additionally, Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) has announced the acquisition of the DNA and RNA businesses of Officinae Bio. This acquisition is expected to bring advanced AI-driven digital platforms and automation solutions for large and complex DNA assembly and mRNA synthesis, which will complement the company’s existing offerings. The acquisition will also enhance the company’s ability to provide end-to-end services from sequence to drug product. Furthermore, Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is leveraging its research collaborations with nine top-tier academic institutions, including the University of California, San Diego, to accelerate the adoption of the latest technologies and drive long-term value creation.